Allergan, Sightsavers and the IAPB Announce the ‘Keep Sight’ Initiative to Address Glaucoma in Ganjam, Odisha

▴ Allergan Sightsavers and the IAPB Announce the Keep Sight Initiative to Address
A unique initiative which joins an innovative eyecare biopharma leader with international charities to train healthcare professionals to diagnose and treat patients with glaucoma

Allergan, Sightsavers and the International Agency for the Prevention of Blindness (IAPB) today announced the launch of its unique joint initiative - ‘Keep Sight India’ – a community based glaucoma screening progamme to prevent glaucoma-related vision loss in Ganjam District, Odisha. The pilot kicked off in October 2019 in partnership with Sightsavers local partner, Sankara Eye Hospital.The progamme provides training for healthcare professionals to screen at-risk populations, ensure early and accurate diagnosis and provide appropriate treatment and long-term care in an effort to make a positive impact on people with glaucoma at all levels of comprehensive eye care.

The first outreach camp was organised on December 3rd, 2019 on World Disability Day and subsequently four outreach camps were conducted under the pilot project. The outreach camps included services like vision testing, refraction, IOP measurement, fundus photography, spectacle dispensing, cataract identification, referral services and counselling services. To date 8276 people have been screened for glaucoma in these four outreach camps, from which 749 glaucoma suspects were identified and referred to the base hospital.2

Sightsavers India CEO, RN Mohanty said, “We are excited to be partnering with Allergan, an organisation with a long legacy in eyecare. Sightsavers too like Allergan is committed in finding and providing effective solutions for patients suffering with glaucoma, which is one of the leading causes of irreversible blindness. The typical barriers we face on ground include inadequate human resources, a lack of awareness and limited access to medical treatments. The partnership between Sightsavers and Allergan is an example of the vital associations that are needed to fight avoidable blindness and deliver better services at the community level.”

Dr. SY Quraishi, Honorary Chairman Sightsavers India Board and former Chief Election Commissioner, India said, “Nearly 75% of sight loss can be cured or prevented, so it’s an area where initiatives like this can have a strong impact where it is needed the most. I’m happy to know that people in and around Ganjam will become aware about Glaucoma and take adequate corrective measures which are now accessible via eye screening camps in the community and services at the Sankara Eye Hospital, Samarjhola.”

“India will play a crucial role in meeting WHO’s targets for eye health,” said Joanna Conlon, Director of Development and Communications, IAPB. “The country is already at the forefront of delivering people - centered solutions for eye care. Keep Sight will work with Indian partners to support and extend India’s successes around eye health and glaucoma. IAPB is committed to universal eye health. Sightsavers has decades of experience in delivering eye health in the region. Together with Allergan, they are keen to make a real difference for people with Glaucoma. Together, we will work to support India’s eye care strategies.”

“Allergan is honoured to partner with Sightsavers and IAPB on ‘Keep Sight’; their wealth of knowledge and expertise, combined with our passion for science and solutions will have a real impact on our shared goal of reducing the high burden of irreversible blindness in the country. For almost two decades Allergan has been committed to developing novel approaches to preserve visual function and prevent blindness caused by glaucoma. ‘Keep Sight’ is an initiative that will make a real difference to people with glaucoma in India,” said Gopinath Kesavan, Associate Director, Eyecare, Allergan India

Tags : #Odissa #Ganjam #Allergan #Csr #Glaucoma

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Unlocking New Horizons: Gene Therapies for Hearing Loss and BlindnessMay 10, 2024
Kerala Health Alert: West Nile Fever Cases Confirmed in Thrissur, Malappuram, and KozhikodeMay 10, 2024
Managing Health in the Heat: Demand for Medications Surges in IndiaMay 10, 2024
Sudhamukti Ayurvedic Medicine by OJSP: A New Era in Diabetes ManagementMay 10, 2024
The Role of Genetic Profiles in Alzheimer’s Therapy: APOE4 and Treatment ResponsesMay 08, 2024
Assessing Covishield Safety: Indian Research Offers Reassurance Amidst Rare Side Effect DiscussionsMay 08, 2024
Quadria Capital Invests $102 Million in NephroPlus to Boost Dialysis Services Across AsiaMay 08, 2024
Reducing Stigma, One Story at a Time: Media's Role in Mental HealthMay 07, 2024
When Your Body Makes Beer: Exploring the Curious Case of Auto-Brewery SyndromeMay 07, 2024
Hair Today, Gone Tomorrow: Why Guys Go Bald Before Marriage May 07, 2024
Menopausal Transitions and Mental Health: UCL Study Highlights Increased Depression RiskMay 07, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Vasavi Club of Buddhapurnima organised #GoVote, a vote awareness driveMay 06, 2024
Harnessing AI for Early Alzheimer's Disease Diagnosis: IIT Indore's BreakthroughMay 06, 2024
Aurobindo Pharma's Bhiwadi Facility Under FDA Scrutiny: Understanding the ObservationsMay 06, 2024
Exploring the Role of Mediator Protein Complex in Cell Division: Implications for Disease ManagementMay 06, 2024
Akshay Tritiya Parna Mahotsav is to be held in the cityMay 04, 2024
Bharti Singh's Battle with Gallstones: Symptoms, Precautions, and Natural RemediesMay 04, 2024
Empowering Women's Health: New Mammogram GuidelinesMay 04, 2024
Rising Temperatures, Rising Risks: Addressing the Challenges of Heat StressMay 04, 2024